Login / Signup
Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
Eric Laffon
Roger Marthan
Published in:
European journal of nuclear medicine and molecular imaging (2018)
Keyphrases
</>
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
diffuse large b cell lymphoma
patient reported outcomes